Chitosan nanoparticles for prolonged delivery of timolol maleate

被引:56
作者
Agnihotri, Sunil A. [1 ]
Aminabhavi, Tejraj M. [1 ]
机构
[1] Karnatak Univ, Ctr Excellence Polymer Sci, Drug Delivery Div, Dharwad 580003, Karnataka, India
关键词
chitosan; nanoparticles; timolol maleate; controlled release; desolvation; factorial design;
D O I
10.1080/03639040701384942
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Timolol maleate-loaded chitosan (CS) nanoparticles were prepared by desolvation method. Experimental variables such as molecular weight of CS and amount of crosslinking agent were varied to study their effect on drug entrapment efficiency, size and release rates of nanoparticles. Chemical stability of timolol maleate (TM) and crosslinking of CS were confirmed by Fourier transform infrared spectroscopy. Differential scanning calorimetric studies were performed on drug-loaded nanoparticles to investigate crystalline nature of the drug after entrapment. Results indicated amorphous dispersion of drug in the polymer matrix. Scanning electron microscopy revealed irregularly shaped particles. Mean particle size of nanoparticles ranged between 118 and 203 nm, while zeta potential ranged between +17 and +22 mV. Entrapment efficiency of nanoparticles ranged between 47.6 and 63.0%. In-vitro release studies were performed in phosphate buffer saline of pH 7.4. A slow release of TM up to 24 h was observed. A 3 2 full factorial design was employed and secondorder regression models were used to study the response (% drug release at 4 h). Release data as analyzed by an empirical relationship suggested that drug release deviated from the Fickian trend.
引用
收藏
页码:1254 / 1262
页数:9
相关论文
共 33 条
[11]   Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention [J].
Felt, O ;
Furrer, P ;
Mayer, JM ;
Plazonnet, B ;
Buri, P ;
Gurny, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 180 (02) :185-193
[12]   Bioadhesive microspheres for ophthalmic administration of acyclovir [J].
Genta, I ;
Conti, B ;
Perugini, P ;
Pavanetto, F ;
Spadaro, A ;
Puglisi, G .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (08) :737-742
[14]   Mucoadhesive ocular insert based on thiolated poly(acrylic acid):: development and in vivo evaluation in humans [J].
Hornof, M ;
Weyenberg, W ;
Ludwig, A ;
Bernkop-Schnürch, A .
JOURNAL OF CONTROLLED RELEASE, 2003, 89 (03) :419-428
[15]   Modified beta-cyclodextrin (SBE7-beta-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits [J].
Jarho, P ;
Jarvinen, K ;
Urtti, A ;
Stella, VJ ;
Jarvinen, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (03) :263-269
[16]   Vesicular systems in ocular drug delivery: an overview [J].
Kaur, IP ;
Garg, A ;
Singla, AK ;
Aggarwal, D .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 269 (01) :1-14
[17]  
Kaur IP, 2002, DRUG DEV IND PHARM, V28, P473
[18]   Ocular bioavailability of ciprofloxacin in sustained release formulations [J].
Ke, TL ;
Cagle, G ;
Schlech, B ;
Lorenzetti, OJ ;
Mattern, J .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2001, 17 (06) :555-563
[19]  
KNAPCZYK J, 1989, CHITIN CHITOSAN SOUR, P657
[20]  
Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1